Mucopolysaccharidosis type i (Hurler syndrome) and anesthesia: The impact of bone marrow transplantation, enzyme replacement therapy, and fiberoptic intubation on airway management

Paediatric Anaesthesia

Volumn 22, Issue 8, 2012, Pages 745-751

  Kirkpatrick, Katherine ^a   Ellwood, James ^a   Walker, Robert W M ^a  

^a ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Anesthesia; Difficult airway; Hurler syndrome; Mucopolysaccharidoses

Indexed keywords

HALOTHANE; KETAMINE; LARONIDASE; NITROUS OXIDE; OXYGEN; PROPOFOL; SEVOFLURANE;

ADOLESCENT; ADULT; AIRWAY; ANESTHESIA; ANESTHESIA INDUCTION; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL ARTICLE; ENDOTRACHEAL INTUBATION; ENZYME REPLACEMENT; FIBEROPTIC ENDOTRACHEAL INTUBATION; HUMAN; HURLER SYNDROME; INFANT; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; AIRWAY MANAGEMENT; ANESTHESIA; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; ENZYME REPLACEMENT THERAPY; FEMALE; FIBER OPTIC TECHNOLOGY; HUMANS; INFANT; LARYNGEAL MASKS; LARYNGOSCOPY; MALE; MUCOPOLYSACCHARIDOSIS I; RETROSPECTIVE STUDIES; TREATMENT FAILURE;

EID: 84863720973     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2012.03897.x     Document Type: Article

References (15)

1. Smith RM,. Anaesthesia for Infants and Children, 4th edn. St Louis, MO: C.V. Mosby Co, 1980: 533-536.
2. Moores C, Rogers JG, McKenzie IM, et al. Anaesthesia for children with mucopolysaccharidoses. Anaesth Intensive Care 1996; 24: 259-463.
3. Walker RW, Darowski M, Morris P, et al. Anaesthesia and mucopolysaccharidoses. A review of airway problems in children. Anaesthesia 1994; 49: 1078-1084.
4. Baines D, Keneally J,. Anaesthetic implications of the mucopolysaccharidoses: a fifteen-year experience in a children's hospital. Anaesth Intensive Care 1983; 11: 198-202.
5. Hobbs JR, Hugh-Jones K, Barrett AJ, et al. Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation. Lancet 1981; 2: 709-712.
6. Wraith JE, Clarke LA, Beck M, et al. Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human α-l-iduronidase (laronidase). J Pediatr 2004; 144: 581-588.
7. Walker RWM, Allen DL, Rothera M,. A fibreoptic intubation technique for children with mucopolysaccaridoses using the laryngeal mask airway. Paediatr Anaesth 1997; 7: 421-426.
8. Neufeld EF, Muenzer J,. The mucopolysaccharidoses. In:, Scriver CR, Beaudet AL, Valle D, Sly WS, Childs B, Kinzler KW, Vogelstein B, eds. The Metabolic and Molecular Basis of Inherited Disease. New York, NY: McGraw Hill, 2001: pp. 3421-3452.
9. Muenzer J, Wraith JE, Clarke LA,. Mucopolysaccharidosis I: management and treatment guidelines. Pediatrics 2009; 123: 19-29.
10. Boelens JJ, Wynn RF, O'Meara A, et al. Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure. Bone Marrow Transplant 2007; 40: 225-233.
11. Weisstein JS, Delgado E, Steinbach LS, et al. Musculoskeletal manifestations of Hurler syndrome: long term follow up after bone marrow transplantation. J Pediatr Orthop 2004; 24: 97-101.
12. Sifuentes M, Doroshow R, Hoft R, et al. A follow -up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years. Mol Genet Metab 2007; 90: 171-180.
13. Braunlin EA, Berry JM, Whitley CB,. Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I. Am J Cardiol 2006; 98: 416-418.
14. Walker RWM,. The laryngeal mask airway in the difficult paediatric airway: an assessment of positioning and use in fibreoptic intubation. Paediatr Anaesth 2000; 10: 53-58.
15. Walker RWM, Colovic V, Robinson DN, et al. Postobstructive pulmonary oedema during anaesthesia in children with mucopolysaccharidoses. Paediatr Anaesth 2003; 13: 441-447.